The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities.
An article from
Dive Brief
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt the technology across many day-to-day activities.
Published May 20, 2026
Permission granted by Bristol-Myers Squibb
The biopharma company will use the AI model across research, drug development, manufacturing, and commercial and medical affairs
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
As Anthropic continues to push into the enterprise market, this new entity aims to reach mid-size companies that are clients of…
Anthropic's Claude large language model family will be incorporated into some of IBM's software development products.
We believe that AI can give nonprofits back some of their precious time. This work is central to our mission as a public benefit…
Anthropic said its latest agreement with Google expands on a longstanding partnership between the two companies.
